Nitzan Rosenfeld

25.8k citations

75 papers · 13.3k indexed · 9 hit papers · h-index 37

Molecular Biology top 0.5%
Cancer Research top 0.05%
Oncology top 0.5%
Pulmonary and Respiratory Medicine top 0.5%
Pathology and Forensic Medicine top 0.5%

Co-authors: Michael B. Elowitz Uri Alon Carlos Caldas James D. Brenton Davina Gale Muhammed Murtaza Tim Forshew Dana W.Y. Tsui
Topics: Cancer Genomics and Diagnostics (53 papers)Lung Cancer Treatments and Mutations (19 papers)Molecular Biology Techniques and Applications (15 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Nature Science New England Journal of Medicine
Partner nations: United Kingdom United States Israel

In The Last Decade

Nitzan Rosenfeld

75 papers receiving 13.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liquid biopsies come of age: towards implementation of circulating tumour DNA

2017 1.8k citations Jonathan C. M. Wan, Charles Massie et al. profile →
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

2013 1.6k citations Sarah‐Jane Dawson, Dana W.Y. Tsui et al. profile →
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

2013 1.2k citations Sarah‐Jane Dawson, Dana W.Y. Tsui et al. profile →
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis

2007 1.1k citations Eti Meiri, Yael Spector et al. profile →
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA

2012 975 citations Tim Forshew, Christine Parkinson et al. profile →
Gene Regulation at the Single-Cell Level

2005 818 citations Nitzan Rosenfeld, Jonathan W. Young et al. Science profile →
Dynamics of the p53-Mdm2 feedback loop in individual cells

2004 773 citations Galit Lahav, Nitzan Rosenfeld et al. Nature Genetics profile →
Negative Autoregulation Speeds the Response Times of Transcription Networks

2002 543 citations Nitzan Rosenfeld, Michael B. Elowitz et al. Journal of Molecular Biology profile →
The future of early cancer detection

2022 259 citations Nitzan Rosenfeld et al. profile →

Peers

Countries citing papers authored by Nitzan Rosenfeld

Since Specialization

Citations

This map shows the geographic impact of Nitzan Rosenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nitzan Rosenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nitzan Rosenfeld more than expected).

Fields of papers citing papers by Nitzan Rosenfeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nitzan Rosenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nitzan Rosenfeld. The network helps show where Nitzan Rosenfeld may publish in the future.

Co-authorship network of co-authors of Nitzan Rosenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Nitzan Rosenfeld. A scholar is included among the top collaborators of Nitzan Rosenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nitzan Rosenfeld. Nitzan Rosenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study 2025 ·PLoS Medicine ·(unknown),Christopher G. Smith,Koen J. Hartemink,Robert C. Rintoul,Davina Gale,Kim Monkhorst,(unknown),Anna Paterson,Daan van den Broek,Nitzan Rosenfeld,Michel M. van den Heuvel,(unknown)	2
2	Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC). 2023 ·Journal of Clinical Oncology ·(unknown),Jinfeng Zou,Lisa Avery,Anna Spreafico,John Waldron,David P. Goldstein,Aaron R. Hansen,John Cho,John R. de Almeida,Andrew Hope,Ali Hosni,Ezra Hahn,Bayardo Perez‐Ordoñez,Zhen Zhao,Christopher G. Smith,(unknown),Nitzan Rosenfeld,(unknown),Scott V. Bratman,Lillian L. Siu	1
3	Refined characterization of circulating tumor DNA through biological feature integration 2022 ·Scientific Reports ·Havell Markus,Dineika Chandrananda,Elizabeth Moore,Florent Moulière,James Morris,James D. Brenton,Christopher G. Smith,Nitzan Rosenfeld	33
4	Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA 2021 ·Genome Research ·Irena Hudecova,Christopher G. Smith,Robert Hänsel‐Hertsch,Chandra Sekhar Reddy Chilamakuri,James A. Morris,(unknown),Katrin Heider,Dineika Chandrananda,Wendy N. Cooper,Davina Gale,Javier García-Corbacho,Simon Pacey,Richard D. Baird,Nitzan Rosenfeld,Florent Moulière	58
5	Detection of ctDNA from Dried Blood Spots after DNA Size Selection 2020 ·Clinical Chemistry ·Katrin Heider,Jonathan C. M. Wan,James Hall,Jelena Belic,(unknown),Irena Hudecova,Davina Gale,Wendy N. Cooper,Pippa Corrie,James D. Brenton,Christopher G. Smith,Nitzan Rosenfeld	36
6	Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene 2020 ·PLoS ONE ·Lorenza Mittempergher,Anna Piskorz,Astrid J Bosma,Magali Michaut,G. Bea A. Wisman,Roelof J.C. Kluin,Marja Nieuwland,Wim Brugman,(unknown),Francesco Marass,James Morris,Nitzan Rosenfeld,Mercedes Jimenez‐Liñan,Steven de Jong,Ate G.J. van der Zee,James D. Brenton,René Bernards	2
7	Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients – initial observations 2020 ·PLoS ONE ·(unknown),Lise Barlebo Ahlborn,Gitte Fredberg Persson,Dineika Chandrananda,(unknown),Barbara Malene Fischer,Seppo W. Langer,Miglė Gabrielaitė,Andreas Kjær,Nitzan Rosenfeld,Florent Moulière,Oľga Østrup,Ivan R. Vogelius,Søren M. Bentzen	14
8	Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models 2018 ·Cancer Research ·Richard Mair,Florent Moulière,Christopher G. Smith,Dineika Chandrananda,Davina Gale,Francesco Marass,Dana W.Y. Tsui,Charles Massie,Alan J. Wright,Colin Watts,Nitzan Rosenfeld,Kevin M. Brindle	68
9	Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients 2018 ·Journal of Molecular Diagnostics ·(unknown),Dana W.Y. Tsui,Heather Biggs,(unknown),Sarah‐Jane Dawson,Charlotte Hodgkin,Linda Jones,Christine Parkinson,Anna Piskorz,Francesco Marass,Dineika Chandrananda,Elizabeth Moore,James Morris,Vincent Plagnol,Nitzan Rosenfeld,Carlos Caldas,James D. Brenton,Davina Gale	84
10	Osimertinib benefit inEGFR-mutant NSCLC patients withT790M-mutation detected by circulating tumour DNA 2017 ·Annals of Oncology ·Jordi Remón,Caroline Caramella,Cécile Jovelet,Ludovic Lacroix,Andrew Lawson,Sarah Smalley,Karen Howarth,Davina Gale,(unknown),Vincent Plagnol,Nitzan Rosenfeld,David Planchard,M.V. Bluthgen,Anas Gazzah,(unknown),Claudio Nicotra,Édouard Auclin,Jean‐Charles Soria,Benjamin Besse	133
11	P3.02b-102 Osimertinib Benefit in ctDNA T790M Positive, EGFR-Mutant NSCLC Patients 2017 ·Journal of Thoracic Oncology ·Jordi Remón,Caroline Caramella,(unknown),Ludovic Lacroix,Andrew Lawson,Sarah Smalley,Karen Howarth,Davina Gale,Nitzan Rosenfeld,Emma Green,Vincent Plagnol,David Planchard,(unknown),(unknown),(unknown),Claudio Nicotra,Jean‐Charles Soria,Benjamin Besse	2
12	Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer 2017 ·Scientific Reports ·Keval Patel,Kristan E. van der Vos,Christopher G. Smith,Florent Moulière,Dana W.Y. Tsui,James Morris,Dineika Chandrananda,Francesco Marass,Daan van den Broek,David E. Neal,Vincent J. Gnanapragasam,Tim Forshew,Bas W. van Rhijn,Charles Massie,Nitzan Rosenfeld,Michiel S. van der Heijden	84
13	Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study 2016 ·PLoS Medicine ·Christine Parkinson,Davina Gale,Anna Piskorz,Heather Biggs,Charlotte Hodgkin,Helen Addley,(unknown),Penelope Moyle,Evis Sala,Karen Sayal,Karen Hosking,Ioannis Gounaris,Mercedes Jimenez‐Liñan,Helena Earl,Wendi Qian,Nitzan Rosenfeld,James D. Brenton	204
14	Measuring single-cell gene expression dynamics in bacteria using fluorescence time-lapse microscopy 2011 ·Nature Protocols ·Jonathan W. Young,James Locke,Alphan Altınok,Nitzan Rosenfeld,(unknown),Peter S. Swain,Eric Mjolsness,Michael B. Elowitz	268
15	Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma 2009 ·Journal of Clinical Oncology ·Danit Lebanony,Hila Benjamin,Shlomit Gilad,(unknown),Avital Dov,Karin Ashkenazi,N. E. Gefen,Shai Izraeli,Gideon Rechavi,Harvey I. Pass,Daisuke Nonaka,Junjie Li,Yael Spector,Nitzan Rosenfeld,Ayelet Chajut,Dalia Cohen,Ranit Aharonov,Mahesh Mansukhani	326
16	Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression 2009 ·The International Journal of Biochemistry & Cell Biology ·Iris Barshack,Eti Meiri,Shai Rosenwald,Danit Lebanony,(unknown),Sarit Aviel‐Ronen,Kinneret Rosenblatt,Sylvie Polak‐Charcon,(unknown),(unknown),Merav Zepeniuk,(unknown),Lahav Cohen,Sarit Tabak,Dalia Cohen,Zvi Bentwich,Nitzan Rosenfeld	44
17	A Fluctuation Method to Quantify In Vivo Fluorescence Data 2006 ·Biophysical Journal ·Nitzan Rosenfeld,Theodore J. Perkins,Uri Alon,Michael B. Elowitz,Peter S. Swain	53
18	Gene Regulation at the Single-Cell Levelbreakdown → 2005 ·Science ·Nitzan Rosenfeld,Jonathan W. Young,Uri Alon,Peter S. Swain,Michael B. Elowitz	818
19	Dynamics of the p53-Mdm2 feedback loop in individual cellsbreakdown → 2004 ·Nature Genetics ·Galit Lahav,Nitzan Rosenfeld,Alex Sigal,Naama Geva‐Zatorsky,Arnold J. Levine,Michael B. Elowitz,Uri Alon	773
20	Negative Autoregulation Speeds the Response Times of Transcription Networksbreakdown → 2002 ·Journal of Molecular Biology ·Nitzan Rosenfeld,Michael B. Elowitz,Uri Alon	543

About Nitzan Rosenfeld

Nitzan Rosenfeld is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Biophysics, having authored 75 papers that have together received 13.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (53 papers), Lung Cancer Treatments and Mutations (19 papers) and Molecular Biology Techniques and Applications (15 papers). The work is most often cited by research in Cancer Research (7.7k citations), Oncology (3.7k citations) and Molecular Biology (7.7k citations). Nitzan Rosenfeld has collaborated with scholars based in United Kingdom, United States and Israel. Frequent co-authors include Michael B. Elowitz, Uri Alon, Carlos Caldas, James D. Brenton, Davina Gale, Muhammed Murtaza, Tim Forshew, Dana W.Y. Tsui, Florent Moulière and Sarah‐Jane Dawson. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact